These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 403725)

  • 21. B cell activation in patients with active procainamide induced lupus.
    Forrester J; Golbus J; Brede D; Hudson J; Richardson B
    J Rheumatol; 1988 Sep; 15(9):1384-8. PubMed ID: 3264337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on human blood lymphocytes with iC3b (type 3) complement receptors: III. Abnormalities in patients with active systemic lupus erythematosus.
    Gray JD; Lash A; Bakke AC; Kitridou RC; Horwitz DA
    Clin Exp Immunol; 1987 Mar; 67(3):556-64. PubMed ID: 2955974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus.
    Jin O; Sun LY; Zhou KX; Zhang XS; Feng XB; Mok MY; Lau CS
    Clin Rheumatol; 2005 Apr; 24(2):107-10. PubMed ID: 15818511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.
    Takeuchi T; Tanaka S; Steinberg AD; Matsuyama T; Daley J; Schlossman SF; Morimoto C
    J Clin Invest; 1988 Oct; 82(4):1288-94. PubMed ID: 2971675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus.
    Dixon JA; Mulhern LM; Whiteside TL; Luksick J
    J Rheumatol; 1980; 7(4):544-6. PubMed ID: 6999152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-lymphocyte subpopulation in untreated SLE. Variations with disease activity.
    Rivero SJ; Llorente L; Díaz-Jouanen E; Alarcón-Segovia D
    Arthritis Rheum; 1977; 20(6):1169-73. PubMed ID: 332183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
    Weill BJ; Renoux ML
    Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII.
    Milner GR; Holt PJ; Bottomley J; Maciver JE
    J Clin Pathol; 1977 Aug; 30(8):770-3. PubMed ID: 599192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum factors inhibiting cellular immunity in systemic lupus erythematosus].
    Lavalle C; Alcocer J; Gudiño J; Fraga A
    Prensa Med Mex; 1978; 43(1-2):16-20. PubMed ID: 309127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced systemic lupus erythematosus.
    Weinstein A
    Prog Clin Immunol; 1980; 4():1-21. PubMed ID: 6992215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLE syndrome with keratoconjunctivitis sicca, a side-effect of practolol [proceedings].
    Poelhuis JW; Donders PC; Schweitzer NM
    Ophthalmologica; 1977; 175(1):40. PubMed ID: 904901
    [No Abstract]   [Full Text] [Related]  

  • 32. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).
    Morimoto C
    Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
    Reidenberg MM; Drayer DE
    Angiology; 1986 Dec; 37(12 Pt 2):968-71. PubMed ID: 2433971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accessory cell activity of monocytes in anti-DNA antibody production in systemic lupus erythematosus.
    Sasaki T; Shibata S; Hirabayashi Y; Sekiguchi Y; Yoshinaga K
    Clin Exp Immunol; 1989 Jul; 77(1):37-42. PubMed ID: 2788540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced immune-complex disease.
    Sim E
    Complement Inflamm; 1989; 6(2):119-26. PubMed ID: 2524348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pure red cell aplasia in procainamide induced systemic lupus erythematosus. Report and review of the literature.
    Agudelo CA; Wise CM; Lyles MF
    J Rheumatol; 1988 Sep; 15(9):1431-2. PubMed ID: 3143834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.